{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:19Z","timestamp":1786119439606,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/sap.0b013e3181b143d2","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:37:42Z","timestamp":1268890662000},"page":"435-441","source":"Crossref","is-referenced-by-count":2,"title":["Modified Poly-l-Lactic Acid Injection Technique"],"prefix":"10.1097","volume":"64","author":[{"given":"Jonathan Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Skolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14764170500451404","article-title":"Safety of sculptra: a review of clinical trial data.","volume":"7","author":"Engelhard","year":"2005","journal-title":"J Cosmet Laser Ther"},{"key":"R2-16-20210202","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (new-fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R3-16-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection.","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"key":"R4-16-20210202","first-page":"1336","article-title":"Safety and efficacy of poly-l-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience.","volume":"32","author":"Mest","year":"2006","journal-title":"Dermatol Surg"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1258\/095646206777689116","article-title":"Poly-l-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies.","volume":"17","author":"Barton","year":"2006","journal-title":"Int J STD AIDS"},{"key":"R7-16-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-l-lactic acid for the treatment of HIV-associated facial lipoatrophy.","volume":"52","author":"Burgess","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R8-16-20210202","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1097\/01.prs.0000234846.00139.74","article-title":"Soft-tissue augmentation and the role of poly-l-lactic acid.","volume":"118","author":"Vleggaar","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1097\/01.prs.0000234612.20611.5a","article-title":"Injectable poly-l-lactic acid (sculptra): technical considerations in soft-tissue contouring.","volume":"118","author":"Lam","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"suppl 1","key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.2006.01515.x","article-title":"Dispelling the myth: appropriate use of poly-l-lactic acid and clinical considerations.","volume":"20","author":"Lowe","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"suppl 1","key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01518.x","article-title":"Poly-l-lactic acid: consultation on the injection techniques.","volume":"20","author":"Vleggaar","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14764170701840074","article-title":"Optimizing poly-l-lactic acid use.","volume":"10","author":"Lowe","year":"2008","journal-title":"J Cosmet Laser Ther"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1524-4741.2007.00529.x","article-title":"Correction of chest wall deformity after implant-based breast reconstruction using poly-l-lactic acid (sculptra).","volume":"14","author":"Schulman","year":"2008","journal-title":"Breast J"},{"key":"R14-16-20210202","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cps.2006.09.001","article-title":"Sculptra: the new three-dimensional filler.","volume":"33","author":"Sherman","year":"2006","journal-title":"Clin Plast Surg"},{"key":"R15-16-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.asj.2008.06.005","article-title":"Poly-l-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review.","volume":"28","author":"Kates","year":"2008","journal-title":"Aesthet Surg J"},{"key":"R17-16-20210202","first-page":"72","article-title":"Pathology. 3rd ed.","author":"Fantone","year":"1999"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0190-9622(93)70070-A","article-title":"Histologic features of foreign body reactions in patients infected with human immunodeficiency virus type 1. The military medical consortium for applied retroviral research.","volume":"28","author":"Smith","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R19-16-20210202","article-title":"The Granulomatous Disorders.","author":"James","year":"1999"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/120347540300700107","article-title":"Foreign body granuloma: a new manifestation of immune restoration syndrome.","volume":"7","author":"Murray","year":"2003","journal-title":"J Cutan Med Surg"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SAP.0b013e3181b143d2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:28Z","timestamp":1786040128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000637-201004000-00016"}},"subtitle":["Safety and Efficacy of \u201cCross-Fanning\u201d in Non-HIV-Related Facial Atrophy"],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e3181b143d2","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}